Gijsbert Veerman serves as the Chief Operating Officer at IQVIA Biotech, overseeing global project teams, investigator site services, and therapeutic divisions. With more than 27 years of clinical research experience in the CRO environment and seven years in pre-clinical oncology research, Gijsbert brings a wealth of strategy and operational expertise to his role.
Gijsbert’s leadership experience includes significant roles in data management, clinical operations, quality management and project management across therapeutic areas. Since joining IQVIA in 2022 as vice president and global therapeutic area head for oncology, he has contributed early and late phase oncology drug development expertise, offering strategic and study design insights to emerging biopharma and biotech customers. His experience spans early phase studies, including first-in-human trials, as well as late phase drug development and biosimilars.
Gijsbert holds a Bachelor of Science in Clinical Chemistry from Hoge School Utrecht, Netherlands, which has provided a solid foundation for his extensive career in clinical research.
Living just outside of Amsterdam, Gijsbert is married and has one child. In his free time, he enjoys long distance hiking, photography and reading.